Â¥
16.36
Sep 30
Business Description
Hainan Shuangcheng Pharmaceuticals Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100001K63
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.23 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | -2.19 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 11.76 | |||||
Beneish M-Score | -2.22 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.3 | |||||
3-Year EBITDA Growth Rate | 3.7 | |||||
3-Year EPS without NRI Growth Rate | 24.6 | |||||
3-Year FCF Growth Rate | 16.2 | |||||
3-Year Book Growth Rate | -2.4 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 99.95 | |||||
9-Day RSI | 99.39 | |||||
14-Day RSI | 98 | |||||
6-1 Month Momentum % | -15.94 | |||||
12-1 Month Momentum % | -31.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.08 | |||||
Quick Ratio | 0.59 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 386.56 | |||||
Days Sales Outstanding | 33.14 | |||||
Days Payable | 78.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1 | |||||
Shareholder Yield % | 0.54 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 62.82 | |||||
Operating Margin % | -22.11 | |||||
Net Margin % | -39.87 | |||||
FCF Margin % | -23.85 | |||||
ROE % | -15.62 | |||||
ROA % | -9.13 | |||||
ROIC % | -5.41 | |||||
3-Year ROIIC % | -52.72 | |||||
ROC (Joel Greenblatt) % | -19.25 | |||||
ROCE % | -13.66 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 36.19 | |||||
PB Ratio | 15 | |||||
Price-to-Tangible-Book | 24.79 | |||||
Price-to-Operating-Cash-Flow | 1258.46 | |||||
EV-to-EBIT | -79.4 | |||||
EV-to-EBITDA | -79.4 | |||||
EV-to-Revenue | 36.14 | |||||
EV-to-FCF | -151.54 | |||||
Price-to-Projected-FCF | 40.9 | |||||
Price-to-Median-PS-Value | 3.96 | |||||
Earnings Yield (Greenblatt) % | -1.26 | |||||
FCF Yield % | -0.67 | |||||
Forward Rate of Return (Yacktman) % | -6.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Hainan Shuangcheng Pharmaceuticals Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 191.809 | ||
EPS (TTM) (Â¥) | -0.182 | ||
Beta | -0.37 | ||
Volatility % | 220.64 | ||
14-Day RSI | 98 | ||
14-Day ATR (Â¥) | 0.648885 | ||
20-Day SMA (Â¥) | 8.218 | ||
12-1 Month Momentum % | -31.68 | ||
52-Week Range (Â¥) | 3.67 - 16.36 | ||
Shares Outstanding (Mil) | 414.69 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hainan Shuangcheng Pharmaceuticals Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hainan Shuangcheng Pharmaceuticals Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Hainan Shuangcheng Pharmaceuticals Co Ltd Frequently Asked Questions
What is Hainan Shuangcheng Pharmaceuticals Co Ltd(SZSE:002693)'s stock price today?
When is next earnings date of Hainan Shuangcheng Pharmaceuticals Co Ltd(SZSE:002693)?
Does Hainan Shuangcheng Pharmaceuticals Co Ltd(SZSE:002693) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |